Preliminary Observations of a Substrate-Based Radiotracer Biosensor for In Vivo Positron Emission Tomography Imaging of Tumor Transmembrane Protease ST14
ACS Sensors · 2025
DOI: 10.1021/acssensors.4c03476 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, 2025. Verfasst von Tukang Peng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 2…. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Biosensing Techniques, Radiopharmaceuticals, Neoplasms. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Shanghai Jiao Tong University, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Imaging protease proteolysis with positron emission tomography (PET) has not been well documented in the literature, primarily due to the absence of suitable radiotracers. This study aims to develop a substrate-based radiotracer biosensor for ST14 protease to facilitate direct in vivo PET imaging of proteolysis. The design of the substrate-based radiotracer RQARK-DOTA-68Ga is characterized by the inclusion of an ST14 substrate RQAR moiety and a Lys-DOTA-68Ga moiety, linked via an ST14 cleavage site. The enzymatic cleavage of this radiotracer by ST14 protease was characterized in vitro, and the proteolysis of ST14 was further confirmed through in vivo PET imaging in tumors expressing ST14. RQARK-DOTA-68Ga was specifically cleaved by ST14 protease to yield Lys-DOTA-68Ga and RQAR moieties, whereas the d-isomer, rqark-DOTA-68Ga, was not susceptible to cleavage by ST14 protease. In vivo PET imaging demonstrated high tumor uptake of radioactive signal postinjection RQARK-DOTA-68Ga in ST14-expressing AsPC-1 xenografts, with optimal accumulation observed 1 h postinjection. In contrast, the d-isomer radiotracer, rqark-DOTA-68Ga, exhibited negligible tumor uptake, indicating a distinct preference for the substrate-based radiotracer in regions of ST14-mediated proteolysis. Radio-HPLC analysis following extraction from AsPC-1 tumors injected with RQARK-DOTA-68Ga identified a radioactive peak corresponding to Lys-DOTA-68Ga, confirming enzymatic cleavage and the generation of the anticipated radioactive product in the tumor tissue. Preliminary results indicate that a novel strategy for noninvasive in vivo positron emission tomography imaging of the transmembrane protease ST14 in tumors has been introduced through the development and application of a substrate-based radiotracer biosensor. The radiotracer RQARK-DOTA-68Ga, capable of producing imaging signals through structural changes triggered by substrate cleavage, has proven its ST14-targeting potency in both in vitro enzymatic assays and in vivo PET imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 210000, China.
ORCID-Profile: Jianjun Liu, Haitao Zhao
Förderung
- Shanghai Jiao Tong University
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Peng, T., Liu, J., & Zhao, H. (2025). Preliminary Observations of a Substrate-Based Radiotracer Biosensor for In Vivo Positron Emission Tomography Imaging of Tumor Transmembrane Protease ST14. ACS Sensors. https://doi.org/10.1021/acssensors.4c03476
Vancouver
Peng T, Liu J, Zhao H. Preliminary Observations of a Substrate-Based Radiotracer Biosensor for In Vivo Positron Emission Tomography Imaging of Tumor Transmembrane Protease ST14. ACS Sensors. 2025. doi:10.1021/acssensors.4c03476
BibTeX
@article{Peng2025,
author = {Peng, Tukang and Liu, Jianjun and Zhao, Haitao},
title = {Preliminary Observations of a Substrate-Based Radiotracer Biosensor for In Vivo Positron Emission Tomography Imaging of Tumor Transmembrane Protease ST14},
journal = {ACS Sensors},
year = {2025},
doi = {10.1021/acssensors.4c03476}
}
EUVIMED